CTMX Wutah bathi saben saham ing taun lumaku CytomX Corp

CytomX Therapeutics (CTMX) is integrating ESG principles into the development of targeted therapies, adhering to bioethics and environmental standards. The annual EPS growth rate reflects revenue dynamics, with the value holding at -156.30. Financial stability is supported by partner payments and adherence to testing timelines. Business development is based on reducing the toxicity of drugs for solid tumors through innovative antibodies.

Wutah bathi resik saben saham ing taun iki cytomx.com (CTMX): kanggo periode 04.07.2022 - 14.11.2026

Rincian analitis lan laporan data perusahaan CytomX Therapeutics (CTMX)

- rega saiki lan proyeksi nilai saham:

Bagan kutipan CytomX Pharma|CTMX - Bagan rega target

- data kapitalisasi pasar:

Nilai pasar CytomX Corp|CTMX - Nilai Perusahaan

- indikator kapitalisasi buku:

Nilai Buku saben Saham CytomX Therapeutics|CTMX - Aset Bersih Perusahaan|Multiplikator Kapitalisasi Pasar marang Nilai Buku cytomx.com|CTMX - Total Aset Perusahaan

- indikator beban utang lan likuiditas:

Utang Agregat marang Ekuitas CytomX Therapeutics|CTMX - Utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang modal cytomx.com|CTMX - Utang perusahaan|Rasio utang marang aset resik CytomX Corp|CTMX - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan CytomX Therapeutics|Koefisien jangkoan perantara cytomx.com

- rincian bathi lan kelipatan pasar:

CTMX - Bathi resik|Bathi mangsa ngarep CytomX Therapeutics|CTMX - Koefisien rega marang bathi|Rasio prakiraan rega marang bathi CytomX Corp|CTMX - Pangali rega marang bathi tumrap wutah|Koefisien nilai perusahaan marang bathi operasional sadurunge panyusutan CytomX Corp|CTMX - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben siji saham sajrone rolas wulan pungkasan CytomX Therapeutics|CTMX - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan cytomx.com|CTMX - Wutah bathi resik saben saham ing taun iki|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep CytomX Therapeutics

- statistik dodolan lan pendapatan perusahaan:

CTMX - Dodolan perusahaan|Pendapatan mangsa ngarep perusahaan CytomX Pharma|CTMX - Kapitalisasi marang pendapatan|Rasio rega marang pendapatan sing dikarepake CytomX Corp

Analisis dhasar perusahaan:CytomX Pharma (CTMX)

For the biotechnology company CytomX Therapeutics (CTMX), which relies on grants and partnership tranches, this indicator serves as a measure of capital management efficiency in the absence of retail sales. By analyzing the YoY net income per share trend, an investor can see the percentage deviation of the current EPS from the previous year's value, allowing for an assessment of the financial foundation's stability while undergoing clinical trials.

Pesaing utama

Dinamika bathi saben saham ing taun lumaku GERN (Geron Corp)|Wutah bathi saben saham ing taun lumaku Nanobiotix Corp|Wutah bathi saben saham ing taun lumaku BCYC|Wutah bathi ing taun lumaku CATX|Wutah bathi ing taun lumaku genelux.com (GNLX)|Molecular Partners AG - Wutah bathi resik saben saham ing taun iki|Wutah bathi resik saben siji saham kanggo taun lumaku ONCY (Oncolytics Biotech, Inc.)|Lisata - Wutah bathi ing taun lumaku|Dinamika bathi saben saham ing taun lumaku MBRX|galeratx.com (GRTX) - Wutah bathi saben saham ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku mtem.com (MTEM)